RecruitingNot ApplicableNCT07357428

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) to Provide Human Connection Through Communication

Sponsor

Paradromics

Enrollment

2 participants

Start Date

Mar 31, 2026

Study Type

INTERVENTIONAL

Conditions

Stroke Amyotrophic Lateral Sclerosis Dysarthria Cervical Spinal Cord Injury Tetraplegia/Tetraparesis Neuromuscular disease

Summary

The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended to be used as: (1) an assistive communication device to decode imagined language correlates and speech for patients with impaired communication as a result of severe loss of voluntary motor control; and (2) to provide control of computer devices for individuals with severe loss of voluntary motor control of the upper extremity.

Eligibility

Min Age: 22 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Connexus Brain-Computer Interface for people with amyotrophic lateral sclerosis, cervical spinal cord injury, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 22 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.